In final draft guidance, UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has recommended the use of French drug major Sanofi subsidiary Genzyme's multiple sclerosis drug Lemtrada (alemtuzumab).
NICE is appraising alemtuzumab as a treatment for adults with relapsing & remitting multiple sclerosis, a chronic and disabling neurological condition that, as it progresses, can have a substantial negative impact on a person’s quality of life........ Read More - http://www.ms-uk.org/lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
NICE says 'yes' to Genzyme's MS drug Lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1086 Views
-
Last post by Earth
Thu Sep 07, 2017 3:05 pm
-
-
Day 2 of LEmtrada - Round 2
by Grumpster » Thu Aug 24, 2017 1:21 pm » in Campath (Lemtrada, Alemtuzumab) - 1 Replies
- 2020 Views
-
Last post by Grumpster
Tue Aug 29, 2017 4:18 pm
-
-
-
Third course of Lemtrada improves MS patient’s relapse rate
by MSUK » Mon Mar 05, 2018 8:27 am » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 2368 Views
-
Last post by MSUK
Mon Mar 05, 2018 8:27 am
-
-
-
NICE proposes the withdrawal of six disease modifying drugs
by MSUK » Thu Dec 21, 2017 3:47 am » in General Discussion - 1 Replies
- 655 Views
-
Last post by jimmylegs
Thu Dec 21, 2017 6:10 am
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 1605 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in General Discussion - 0 Replies
- 960 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
- 1 Replies
- 787 Views
-
Last post by NHE
Wed Feb 07, 2018 11:27 pm
-
- 9 Replies
- 3169 Views
-
Last post by ElliotB
Wed Jan 09, 2019 1:55 pm
-
- 0 Replies
- 2878 Views
-
Last post by r7111
Mon Nov 06, 2017 11:11 am
